Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 23,388 shares at $6.29 ($147K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Seasonal sale ($147k) by President and CEO — this insider has traded KPTI in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.29 | 11,694 | $74K | 50.0% |
| 2 | $6.29 | 11,694 | $74K | 50.0% |
| Total | $6.29 avg | 23,388 | $147K | 100% |
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-04-07 | $916 | — | Filing → |